HTA
BHC icon

Haber Trilix Advisors’s Bausch Health BHC Stock Holding History

Haber Trilix Advisors’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$466K Buy
+5,400
New +$426K 0.06% 74

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.59B AUM 9.32% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Haber Trilix Advisors's BHC Position: Q2 2013 in Review

Haber Trilix Advisors opened a new position in Bausch Health (BHC) in Q2 2013: 5,400 shares worth $466K. The stake represents 0.06% of the portfolio and ranks #74 among its holdings.

356 funds tracked by Wall St. Rank hold BHC as of Q2 2013.

  • Haber Trilix Advisors held 5,400 shares of Bausch Health worth $466K as of Q2 2013.
  • Bausch Health was a new Haber Trilix Advisors position in Q2 2013.
  • Bausch Health made up 0.06% of Haber Trilix Advisors's portfolio in Q2 2013, its #74 holding.
  • 356 funds tracked by Wall St. Rank held Bausch Health as of Q2 2013.

Based on Haber Trilix Advisors's 13F filing for Q2 2013, filed 14 Aug 2013.